- Home
- GNK vs SEPN Comparison
GNK vs SEPN Comparison
Compare GNK & SEPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNK
- SEPN
- Stock Information
- Founded
- GNK 2004
- SEPN 2022
- Country
- GNK United States
- SEPN United States
- Employees
- GNK N/A
- SEPN N/A
- Industry
- GNK Marine Transportation
- SEPN
- Sector
- GNK Consumer Discretionary
- SEPN
- Exchange
- GNK Nasdaq
- SEPN NYSE
- Market Cap
- GNK 551.2M
- SEPN 453.2M
- IPO Year
- GNK 2005
- SEPN 2024
- Fundamental
- Price
- GNK $15.06
- SEPN $11.76
- Analyst Decision
- GNK Strong Buy
- SEPN Strong Buy
- Analyst Count
- GNK 3
- SEPN 5
- Target Price
- GNK $18.67
- SEPN $26.75
- AVG Volume (30 Days)
- GNK 738.8K
- SEPN 443.6K
- Earning Date
- GNK 08-06-2025
- SEPN 08-15-2025
- Dividend Yield
- GNK 9.66%
- SEPN N/A
- EPS Growth
- GNK 1259.97
- SEPN N/A
- EPS
- GNK 1.05
- SEPN N/A
- Revenue
- GNK $376,850,000.00
- SEPN $977,000.00
- Revenue This Year
- GNK N/A
- SEPN N/A
- Revenue Next Year
- GNK $2.54
- SEPN $526.96
- P/E Ratio
- GNK $14.46
- SEPN N/A
- Revenue Growth
- GNK N/A
- SEPN 108.76
- 52 Week Low
- GNK $11.20
- SEPN $4.17
- 52 Week High
- GNK $21.08
- SEPN $28.99
- Technical
- Relative Strength Index (RSI)
- GNK 70.85
- SEPN N/A
- Support Level
- GNK $13.85
- SEPN N/A
- Resistance Level
- GNK $14.31
- SEPN N/A
- Average True Range (ATR)
- GNK 0.46
- SEPN 0.00
- MACD
- GNK 0.16
- SEPN 0.00
- Stochastic Oscillator
- GNK 98.23
- SEPN 0.00
About GNK Genco Shipping & Trading Limited New (Marshall Islands)
Genco Shipping & Trading Ltd is an international shipping company specializing in the transportation of iron ore, coal, grain, steel products and other drybulk cargoes. It is involved in the ocean transportation of drybulk cargoes. The company operates in one segment, with two reportable segment: Major and Minor bulk fleet. It generates revenue through time charter agreements, spot market voyage charters, pool agreements and spot market-related time charters. oyage revenues also include the sale of bunkers consumed during short-term time charters pursuant to the terms of the time charter agreement.
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.